Full name
A Prospective, Real-World, Interventional Study To Evaluate The Effect Of Mepolizumab On Achieving Clinical Remission In Participants With Severe Asthma
NCT Number
NCT06041386
Geography
Non-US
Locations
[Location data not yet available]
Primary Endpoints
Percentage (%) of Participants Achieving 4-Component Clinical Remission At Month 12
External Link
https://clinicaltrials.gov/study/NCT06041386
Order
2
Disease
Version
Phase
4